Theravance Biopharma, Inc. (TBPH)
20.48
+0.90
(+4.60%)
USD |
NASDAQ |
Feb 06, 16:00
20.46
-0.02
(-0.10%)
Pre-Market: 20:00
Theravance Biopharma Shareholders Equity (Quarterly) : 232.68M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 631.90M |
| Nektar Therapeutics | 85.09M |
| Innoviva, Inc. | 1.010B |
| Oramed Pharmaceuticals, Inc. | 203.28M |
| Skye Bioscience, Inc. | 32.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 415.46M |
| Total Liabilities (Quarterly) | 182.78M |
| Debt to Equity Ratio | 0.1917 |
| Current Ratio | 9.482 |
| Net Debt Paydown Yield | 0.06% |